PharmaCyte Biotech Officially Begins Development of Diabetes Treatment With First Preclinical Study
February 04, 2015 09:00 ET
|
PharmaCyte Biotech, Inc.
NEW YORK, NY--(Marketwired - February 04, 2015) - PharmaCyte Biotech, Inc. (OTCQB: PMCB) officially moved beyond the discussion of a diabetes treatment to planting its flag in the multi-billion dollar...